Compare AMCR & STE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AMCR | STE |
|---|---|---|
| Founded | 1926 | 1985 |
| Country | Switzerland | United States |
| Employees | 50000 | 3700 |
| Industry | Miscellaneous manufacturing industries | Industrial Specialties |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.6B | 21.6B |
| IPO Year | 2020 | 2018 |
| Metric | AMCR | STE |
|---|---|---|
| Price | $46.93 | $234.36 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 5 |
| Target Price | $51.00 | ★ $275.20 |
| AVG Volume (30 Days) | ★ 3.8M | 677.3K |
| Earning Date | 05-06-2026 | 05-11-2026 |
| Dividend Yield | ★ 6.96% | 1.19% |
| EPS Growth | ★ 643.75 | 27.90 |
| EPS | 2.38 | ★ 7.93 |
| Revenue | ★ $13,640,000,000.00 | $5,935,900,000.00 |
| Revenue This Year | $56.18 | $9.88 |
| Revenue Next Year | $1.49 | $6.32 |
| P/E Ratio | ★ $19.81 | $29.86 |
| Revenue Growth | ★ 9.40 | 8.73 |
| 52 Week Low | $7.67 | $195.14 |
| 52 Week High | $50.94 | $269.44 |
| Indicator | AMCR | STE |
|---|---|---|
| Relative Strength Index (RSI) | 50.95 | 54.96 |
| Support Level | $44.81 | $227.89 |
| Resistance Level | $48.00 | $235.66 |
| Average True Range (ATR) | 1.00 | 3.89 |
| MACD | -0.16 | -0.72 |
| Stochastic Oscillator | 37.53 | 39.98 |
Amcor is a global producer of plastic packaging primarily for the fast-moving consumer goods industry. About 90% of earnings are exposed to the flexible packaging business. This is soft disposable plastic for a variety of food, drink, healthcare, and hygiene products. The remainder of earnings are from the Latin and North American rigids business, which is primarily beverage bottling for the soft drink industry. Operating in more than 35 countries, Amcor has market share in its established regions of North America, Latin America, Europe, and Asia-Pacific. About half of group sales are derived from North America and the remainder is split equally between Western Europe and emerging markets. Australia and New Zealand sales make up less than 5% of group sales.
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 20% from Applied Sterilization Technologies, or AST, and 10% from life sciences services after the divestment of its dental products business.